findmyKOL
Clinical trialNCT00285207CompletedPhase 2Interventional

Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix

SponsorTigris PharmaceuticalsEnrollment147Cervical Intraepithelial NeoplasiaUterine Cervical Dysplasia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A-007 is an investigational therapy which may be effective in the treatment of pre-cancerous cervical dysplasia (abnormal cell growth). The purpose of this study is to evaluate the safety and efficacy of A-007, when used to treat high-grade cervical dysplasia.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama Highlands, Dept. of Ob/gyn

    Birmingham, Alabama, United States

  • Hope Research Institute, Llc

    Phoenix, Arizona, United States

  • Visions Clinical Research-Tucson

    Tucson, Arizona, United States

  • Northern California Research Corp

    Carmichael, California, United States

  • Arrowhead Regional Medical Center

    Colton, California, United States

  • Robin Black Ognp

    Costa Mesa, California, United States

  • Igo Medical Group of San Diego

    San Diego, California, United States

  • Coastal Connecticut Research, Llc

    New London, Connecticut, United States

  • Washington Hospital Center

    Washington D.C., District of Columbia, United States

  • Visions Clinical Research

    Boynton Beach, Florida, United States

  • Global Ob/gyn Centers of Florida

    Pembroke Pines, Florida, United States

  • Physician Care Clinical Research, Llc.

    Sarasota, Florida, United States

  • Ob/gyn Specialists of the Palm Beaches

    West Palm Beach, Florida, United States

  • Mount Vernon Clinical Research, Llc

    Atlanta, Georgia, United States

  • Medical College of Georgia

    Augusta, Georgia, United States

  • East Jefferson Ob/gyn

    Metairie, Louisiana, United States

  • Office of R. Garn Mabey, Md

    Las Vegas, Nevada, United States

  • Jersey Shore University Medical Center

    Neptune City, New Jersey, United States

  • New York Downtown Hospital

    New York, New York, United States

  • Jacobi Medical Center

    The Bronx, New York, United States

  • Montefiore Medical Center-Weiler Division Dept of Ob/gyn & Women'S Health

    The Bronx, New York, United States

  • Greater Cincinnati Ob/gyn, Inc.

    Cincinnati, Ohio, United States

  • University of Oklahoma Health Sciences Center Dept of Ob/gyn

    Oklahoma City, Oklahoma, United States

  • Lehigh Valley Hospital

    Allentown, Pennsylvania, United States

  • Magee-Womens Hospital, Dept of Ob/gyn & Reproductive Services

    Pittsburgh, Pennsylvania, United States

  • South Carolina Oncology Associates

    Columbia, South Carolina, United States

  • Hill Country Ob/gyn

    Austin, Texas, United States

  • Planned Parenthood of Houston & Southeast Texas, Inc.

    Houston, Texas, United States

  • 4601 Old Shepard Place; Bldg 2, Suite 201

    Plano, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

A007Placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2006
Primary completion
30 Apr 2008
Completion
30 Jun 2008
Last update posted
11 Oct 2010
Registered enrollment
147
Registry id
NCT00285207

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.